Trade Summary

6 days ago, FMR LLC, serving as See Remark 1 at Beam Therapeutics Inc. (BEAM), sold 284,860 shares at $35.24 per share, for a total transaction value of $10,039,491.52. Following this transaction, FMR LLC now holds 854,583 shares of BEAM.

This sale represents a 25.00% decrease in FMR LLC's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, June 25, 2026 and publicly disclosed via SEC Form 4 filing on Monday, June 29, 2026 at 2:17 PM ET, 4 days after the trade was made.

Beam Therapeutics Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.